NEW YORK, CARY, NC and MONTREAL, April 29 /PRNewswire-FirstCall/ -- ICBS Limited (ICBS) (Pink Sheets :ICBT) - PharmaDerm, an international pharmaceutical venture between ICBS, McCoy Enterprises and Connell Associates, announced today that they have acquired Vectoris Pharma, a company that has developed an oral insulin, Perosulin(R). Perosulin(R) is a needle-free, non-inhaled insulin delivery technology. Vectoris Pharma Corporation's proprietary platform drug delivery technology for trans-mucosal drug delivery will be commercialized by PharmaDerm. The technology involves the use of a suspension of large macro-molecular drugs, such as insulin, to facilitate systemic delivery via the buccal membrane. The oral mucosa provides a convenient route for macro-molecular delivery of active agents. "Looking ahead in the development of this needle-free platform technology, we envision the immediate development of buccal delivery of insulin followed by pain products such as Fentanyl," said Joe Connell, COO of PharmaDerm. "We will focus our efforts on equipping military and emergency personnel with a convenient, accurate, multiple-dose and needle-free atropine." PharmaDerm will be focused on licensing, developing and commercializing of Perosulin(R). PharmaDerm will work with the US Food and Drug Administration (FDA) and The Health Protection Branch of Canada to gain regulatory approval of Perosulin(R) for commercialization. Nb. This news release includes statements that constitute forward-looking statements. Please be aware that any such forward-looking statements are not guarantees of future performance and involve significant risks and uncertainties, and that actual results may vary materially from those in the forward-looking statements as a result of any number of factors, including the risk factors contained in the Company's disclosure documents. DATASOURCE: Inter Canadian Business Service CONTACT: Randall McCoy, President, McCoy Enterprises, http://www.mccoyllc.com/; Joseph Connell, President & CEO, Connell Associates, (919) 342-5235; Garth McIntosh, President & CEO, ICBS Limited, 888-932-4402, http://www.icbs.ca/

Copyright